IVF clinic in Malmö gains access to new technology for the assessment of embryos

One of Sweden’s largest IVF clinics, Reproduktionsmedicinskt Centrum in Malmö, RMC, has chosen the Primo Vision time lapse system from Vitrolife. This will provide the clinic with a better basis for the assessment of embryos in connection with assisted reproduction.

Since the acquisition of Cryo Management in October 2012 Vitrolife has been able to offer clinics working in the field of assisted reproduction a better basis for assessment of embryos thanks to the product Primo Vision. The product is used in clinics all over the world. 

Approximately 1,200 treatments are performed per year at RMC in Malmö, Sweden. Primo Vision is now being introduced at the clinic.

–  Research is an important part of our work and we see Primo Vision and time-lapse technology both as increased support in our daily work and as an opportunity for us to learn more about embryo development, says Dr. Mona Bungum, Laboratory Director at RMC.

– By using Primo Vision we can not only optimise how we work in the lab but also create a better environment for the embryos we cultivate. We can see that Primo Vision complements our own knowledge in the assessment of embryos. All patients will be offered Primo Vision embryo monitoring.

In Sweden and many other countries only one embryo is usually transferred to the woman in in-vitro fertilisation (IVF). Primo Vision gives detailed information on the development of embryos over time and, together with the clinic’s experience, provides increased support in selecting the embryo that is most likely to implant and result in pregnancy.

Traditional assessment of embryos involves them being taken out of the incubator at determined intervals. This means increased stress for the sensitive embryo. Primo Vision utilizes so-called time lapse technology, which means that a camera takes images of the embryos at short time intervals while they are being cultivated in the incubator. The images are then played back as a film, which makes it possible to study the entire development of the embryo in a short space of time. An assessment can thus be made of which embryos are most likely to result in pregnancy while the embryos are still in the protective environment of the incubator.

For further information, please contact:
Thomas Axelsson, CEO, Vitrolife, phone +46 31-721 80 01
Dr. Mona Bungum, Laboratory Director, Reproduktionsmedicinskt Centrum, phone +46 40-33 21 64